4//SEC Filing
RXi Pharmaceuticals Corp 4
Accession 0001209191-17-007724
$PHIOCIK 0001533040operating
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 5:17 PM ET
Size
5.4 KB
Accession
0001209191-17-007724
Insider Transaction Report
Form 4
Pavco Pamela
Chief Development Officer
Transactions
- Award
Stock option (right to buy)
2017-02-01+7,000→ 7,000 totalExercise: $0.63Exp: 2027-02-01→ Common Stock (7,000 underlying)
Footnotes (1)
- [F1]The stock option vests in equal monthly installments over four years beginning on the first monthly anniversary of the grant date.
Documents
Issuer
RXi Pharmaceuticals Corp
CIK 0001533040
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001533040
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 5:17 PM ET
- Size
- 5.4 KB